MENU
BMRN
AS OF
Nov 20, 04:59 PM (EDT)
Price
$52.51
Change
-$0.05 (-0.10%)
Capitalization
10.1B
97 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
BMRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BioMarin Pharmaceutical (BMRN) Ownership - Who owns BioMarin Pharmaceutical?

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3401
Web
https://www.biomarin.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.1B
P/E Ratio
19.54
Total Cash
1.48B
Projected Growth
0.62
Total Debt
604.24M
Revenue
3.09B
Risk (Beta)
0.56
Dividend Yield
N/A
Total Cash/Share
7.69
Total Debt/Equity
45.30
Revenue/Share
15.72 USD as % of share price

Fundamentals

BMRN
Capitalization
10.1B
P/E Ratio
19.54
Risk (Beta)
0.56
Dividend Yield
N/A
Total Cash
1.48B
Total Cash/Share
7.69
Total Debt
604M
Total Debt/Equity
45.30
Projected Growth (PEG Ratio)
0.62
Revenue/Share (as % of the share price)
15.72%
Revenue
3.09B
ROE
N/A
Book Value
6.06B
P/B Ratio
1.67
Cash Flow
N/A
Earnings
2.72
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
192K
Current Ratio
4.83
Current Revenue Per Employee
255306.90
Dividends Per Share - Security
N/A
EBITDA
772M
Float
N/A
Float - Current
N/A
Gross Income Margin
81.95
Revenue To Assets
7.20
Shares Held By Institutions
18B
Shares Outstanding - Current
192M
Total Liabilities
1.56B
Total Volume MTD
N/A
Value
-1
Gain YTD
-20.037
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BMRN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BMRN showed earnings on October 27, 2025. You can read more about the earnings report here.
View AI-Driven Trading for BMRN
A.I. Advisor
published General Information

General Information

a developer of innovative pharmaceuticals for serious diseases & medical conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3401
Web
https://www.biomarin.com